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Re´sume´. La caracte´risation des alte´rations ge´nomiques tumorales est une e´tape im-
portante dans le de´veloppement de la me´decine personnalise´e en cance´rologie. Parmi les
me´thodes de traitement des donne´es de micro-array, la me´thode GAP (Genome Alteration
Print) de Popova et al. (2009) caracte´rise les mutations a` partir de la segmentation des
signaux du nombre de copies et de la fre´quence de l’alle`le majoritaire obtenus en chaque
site de SNP. Elle utilise un crite`re de´terministe que nous proposons de remplacer par une
mode´lisation probabiliste parame´trique. Nous de´finissons ainsi un mode`le de me´lange
gaussien dont les classes caracte´risent les types de mutations. Ce mode`le est estime´ par
maximum de vraisemblance graˆce a` l’algorithme EM, permettant d’obtenir l’estimation
des parame`tres et la caracte´risation de l’alte´ration tumorale de chaque segment. Dans
notre approche, la plo¨ıdie de la tumeur est de´duite de l’utilisation d’un crite`re pe´nalise´ de
se´lection de mode`le. Notre mode`le est teste´ avec des donne´es simule´es et expe´rimentales.
Mots-cle´s. Mode`le de me´lange, algorithme EM, crite`re BIC, GAP, mutations tu-
morales, SNP micro-array.
Abstract. Characterization of the tumoral genomic alterations is an important step
in the development of personalized medicine in cancerology. Among the methods for
treating micro-array data, the GAP (Genome Alteration Print) method of Popova et al.
(2009) characterizes the mutations based on the segmentation of copy number and B-
allele frequency signals obtained on each SNP. It uses a deterministic criterion that we
propose to replace by a parametric probabilistic model. In this way, we define a Gaussian
mixture model whose classes characterize the mutation types. This model is estimated by
maximum likelihood through the EM algorithm, allowing us to obtain the estimation of
the parameters and the characterization of tumoral alterations on each segment. In our
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approach, the tumoral ploidy is deduced from a penalized model selection criterion. Our
model is tested on simulated data and real data.
Keywords. Mixture model, EM algorithm, BIC criterion, GAP, tumoral mutations,
SNP micro-array.
1 Introduction
Recent research reveals that personalized medicine is arguably the best way to treat can-
cer because of, for example, the immense diversity of underlying genomic alterations. In
order to develop personalized medicine, characterizing the genomic alterations is a vital
component. One way to characterize this alteration is to use a Single Nucleotide Poly-
morphism (SNP) microarray. A SNP is a nucleotide showing variability in the population.
In theory, there are four possible variations, however, in practice, only two variations are
observed which are called A-allele and B-allele, one being common in a large part of the
population. Since the chromosomes in human come in pairs, it is possible for a SNP to
have the genotype AA, BB, AB, or BA. The two former cases are called homozygous SNP,
and the two latter, which are indistinguishable, are called heterozygous SNP.
Using microarrays one can detect genomic alterations such as copy-number variation
and allele-imbalance. Having at hand two microarrays, one for the tumor, the other for
the normal tissue, one can get rid of the unknown proportion p of normal tissues in the
tumor sample which acts as misleading parameter in the tumoral genotype estimation.
However, clinicians are expecting to retrieve this information from only one microarray
of tumor sample. Several methods have been developed for this goal for Illumina plat-
forms. They basically fall into two groups. The first group simultaneously integrates the
segmentation and characterization into one single step by using a hidden Markov model
(HMM). GenoCNA by Sun et al. (2009), OncoSNP by Yau et al. (2010), and GPHMM
by Sun et al. (2011) are several examples of this group. The other group separates the
segmentation and characterization into two separate steps. Examples of this approach
include GAP by Popova et al. (2009) and ASCAT by Loo et al. (2010). Mose´n-Ansorena
et al. (2012) compared between these two groups and found that in general, the two-step
approaches have better performance. The method GAP uses an empiric method to esti-
mate the mutation types and other parameters such as the proportion of normal tissues.
Here we develop a probabilistic model to estimate statistically the parameters and the
mutation types of each segment. Note that Liu et al. (2014) have recently developed an
HMM method called TAFFYS for the other platform Affymetrix.
2 Model
For a SNP, microarray measures the intensities IA and IB of the two alleles which are
proportional to their effective number of copies ngA and n
g
B: IA = γn
g
A and IB = γn
g
B. From
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the two intensities it is possible to derive two variables characterizing the copy-number
and the allele imbalance of the SNP
lrr = log2
(
IA + IB
IRef
)α
= α log2 (CN) + β,
baf =
IB
IA + IB
=
ngB
ngA + n
g
B
,
where CN = ngA + n
g
B is the copy-number, α the contraction factor due to experimental
techniques, β = α log2 (γ/IRef ) dependent on the sample ploidy, and IRef is a reference
intensity. By definition, baf is bounded between 0 and 1. Assume that the proportion
of normal tissues is p > 0 in the biopsy and that the tumor cells have mutation type
with copy-number (nA, nB) for the two alleles, then for heterozygous SNP we have n
g
A =
p+ (1− p)nA and ngB = p+ (1− p)nB. It follows that
lrr = α log2 (2p+ (1− p)(nA + nB)) + β, baf =
p+ nB(1− p)
2p+ (nA + nB)(1− p) .
Measurement values are noisy and we observe on the SNP m
LRRm = lrrm + ηξm, BAFm = bafm + σεm
where ξm and εm are independent random variables with zero mean and unit variance,
and η and σ two positive real numbers. We assume that σ and η do not depend on the SNP.
Structural genomic alterations occurring on intervals of the genome, the values lrrm
and bafm are fixed on one homogeneous interval with respect to the mutation. Hence the
two distributions of BAFm and LRRm can be considered piecewise constant as m varies.
It follows that the mutation characterization can be realized from a proper segmentation
of the two distributions along the genome. Following Popova et al. (2009), we assume
these segmentations have already been realized and we focus on the characterization part.
On each segment, the BAF distributions are symmetric around 1/2, so we confine our-
selves to the range of [0.5, 1] by symmetry.
On the homogeneous segment i of length Ni, are computed averaged values for the
B-allele frequency and the LRR, namely, BAF0i (resp. BAF
1
i ) for the averaged BAF
of the N0i heterozygous (resp. N
1
i homozygous) SNP, and LRRi as the average of the
N0i +N
1
i = Ni values of the LRR on the whole segment.
We assume these observations are independent and follow:
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BAF0i =baf
0
k + ε
0
i
σ√
N0i
,
BAF1i =baf
1
k + ε
1
i
σ√
N1i
,
LRRi =lrrk + ξi
η√
Ni
where k is the class label indicating the underlying mutation type of the segment, which
is characterized by baf1k and lrrk as baf
0
k is always 1. Moreover, ε
0
i , ε
1
i and ξi are assumed
to be independent standardized Gaussian variables thanks to the Central Limit Theorem.
Notice that this is a weak assumption, as N ji is generally much larger than tens. This
leads to two bivariate observations Cjk := (BAF
j
i ,LRRi) around the theoretical positions
cjk := (baf
j
k, lrrk), j = 0, 1, which are associated with the underlying mutation and which
only depend on the unknown parameters p, α, β.
Therefore the segmented observations follow a Gaussian mixture model with centers
at fixed positions (see Figure 1) when p, α and β are known. In this model, the likelihood
of one observation is given by
f(Cji , N
j
i , Ni) =
L∑
`=1
pi` φ(C
j
i ; c`,Σ),
where Σ is the diagonal matrix with diagonal (σ2/N ji , η
2/Ni), φ is the bi-dimensional
Gaussian density and pi`, ` = 1, . . . , L is the mixing proportions, that is the probability
for the observation to be emitted from the center c` which corresponds to one of the c
j
k,
when k varies and j = 0, 1 (while the notation cjk keeps a trace of the connection between
centers associated with one single mutation, c` represents an arbitrary order of all centers.
One can think for example to the lexical order).
3 Maximum likelihood estimation
We denote by n be the number of interval of the segmentation. We use a maximum
likelihood approach to estimate the parameters of our model, namely p the proportion
of normal tissues, α and β linking the copy number to the LRR, η and σ the standard
deviations, together with the mixing proportions pi`, ` = 1, . . . , L.
To this aim, we introduce the membership component indicator zi`, i = 1, 2, . . . , n,
whose value is 1 if the observation i is emitted from the underlying center c`, 0 otherwise.
The parameter p is tricky to infer simultaneously with the other parameters, hence we
use a two-level strategy: for a given p, we implement an EM algorithm (Dempster et al.
1977) to maximize the likelihood when the parameter p is fixed and estimate the other
parameters, and then, use gradient descent method to find the optimal value of p.
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Figure 1: Schematic illustration of the correspondence between the tumoral mutation and
the (baf, lrr) values. Mutations of germ line homozygous are in red. Mutations of germ
line heterozygous are in black and blue. The mutation of the latter characterizes Loss of
Heterozygosity (LOH).
Our model depends on the L considered mutation centers, which need to be selected.
To this end, considering all possible mutations with lrr in the interval [lrrmin, lrrmax],
we select the value lrrmax using a penalized maximum likelihood approach with a BIC
criterion (Schwarz 1978, Keribin 2000), while lrrmin is determined by the parameters p,
α, and β through lrrmin = α log2(2p) + β. The tumoral ploidy is then computed as the
weighted average of the copy numbers which can be deduced from our estimation.
This performs well and results are presented on simulated and real datasets.
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